Sirtex dose

Ended Purchase Order Awarded Last action

Contract number
W81K0024P0119
Awardee
Awarding agency
Obligated
$185,737

Award facts

Opportunity
Contract value 100% obligated
$185,737.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Woburn, MA 01801, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 $185,737
Original award $0

About this award

This is a firm fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Sirtex Medical Inc., a global healthcare company specializing in cancer therapies. The contract, valued at $185,737.00, is for the supply of SIR-Spheres Y-90 resin microspheres, a targeted radiation therapy technology used to treat liver tumors and metastatic colorectal cancer. The contract supports the William Beaumont Army Medical Center in Fort Bliss, Texas and has a period of performance from October 1, 2024 to September 30, 2025. The contract was awarded on a sole source basis under the authority of FAR 13.106-1(b)(i) due to Sirtex's exclusive licensing agreement for the SIR-Spheres product. This contract is not designated as a small business set-aside.

Quick answers

Who was awarded contract W81K0024P0119?

W81K0024P0119 was awarded to Sirtex Medical Inc. by Medical Command (Department of the Army) on October 1, 2024.

How much is contract W81K0024P0119 worth?

The government has obligated $185,737 on W81K0024P0119.

Was contract W81K0024P0119 competed?

The extent of competition for W81K0024P0119 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award